日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Exploring the treatment gap and outcome risks in patients with node-positive, high-risk, HR-positive, HER2-negative early breast cancer: analyses of real-world data

探讨淋巴结阳性、高危、激素受体阳性、HER2阴性早期乳腺癌患者的治疗差距和预后风险:真实世界数据分析

Tolaney, S M; Sammons, S; Sandoval-Leon, A; Cortes, J; Liepa, A M; Grimes, B R; He, D; Cui, Z L; Roose, J; Gathirua-Mwangi, W; Moreira, K; O'Shaughnessy, J; Neven, P; Johnston, S R D; Rugo, H S

4th ESO-ESMO International Consensus Guidelines for Advanced Breast Cancer (ABC 4)†

第四版 ESO-ESMO 晚期乳腺癌国际共识指南 (ABC 4)†

Cardoso, F; Senkus, E; Costa, A; Papadopoulos, E; Aapro, M; André, F; Harbeck, N; Aguilar Lopez, B; Barrios, C H; Bergh, J; Biganzoli, L; Boers-Doets, C B; Cardoso, M J; Carey, L A; Cortés, J; Curigliano, G; Diéras, V; El Saghir, N S; Eniu, A; Fallowfield, L; Francis, P A; Gelmon, K; Johnston, S R D; Kaufman, B; Koppikar, S; Krop, I E; Mayer, M; Nakigudde, G; Offersen, B V; Ohno, S; Pagani, O; Paluch-Shimon, S; Penault-Llorca, F; Prat, A; Rugo, H S; Sledge, G W; Spence, D; Thomssen, C; Vorobiof, D A; Xu, B; Norton, L; Winer, E P

Relationship between IHC4 score and response to neo-adjuvant chemotherapy in estrogen receptor-positive breast cancer

IHC4评分与雌激素受体阳性乳腺癌新辅助化疗疗效的关系

Sheri, A; Smith, I E; Hills, M; Jones, R L; Johnston, S R; Dowsett, M

EGFR/HER2 inhibitor AEE788 increases ER-mediated transcription in HER2/ER-positive breast cancer cells but functions synergistically with endocrine therapy

EGFR/HER2抑制剂AEE788可增强HER2/ER阳性乳腺癌细胞中ER介导的转录,但与内分泌治疗具有协同作用。

Evans, A H; Pancholi, S; Farmer, I; Thornhill, A; Evans, D B; Johnston, S R; Dowsett, M; Martin, L-A

Ghrelin enhances gastric emptying in diabetic gastroparesis: a double blind, placebo controlled, crossover study

生长素释放肽增强糖尿病胃轻瘫患者的胃排空:一项双盲、安慰剂对照、交叉研究

C D R Murray, N M Martin, M Patterson, S A Taylor, M A Ghatei, M A Kamm, C Johnston, S R Bloom, A V Emmanuel

Systematic review of role of bisphosphonates on skeletal morbidity in metastatic cancer

双膦酸盐在转移性癌症骨骼并发症中的作用的系统评价

Ross, J R; Saunders, Y; Edmonds, P M; Patel, S; Broadley, K E; Johnston, S R D

Continuous low dose Thalidomide: a phase II study in advanced melanoma, renal cell, ovarian and breast cancer.

持续低剂量沙利度胺:晚期黑色素瘤、肾细胞癌、卵巢癌和乳腺癌的 II 期研究

Eisen T, Boshoff C, Mak I, Sapunar F, Vaughan M M, Pyle L, Johnston S R, Ahern R, Smith I E, Gore M E

Comparison of new immunohistochemical assay for oestrogen receptor in paraffin wax embedded breast carcinoma tissue with quantitative enzyme immunoassay

比较新型免疫组化检测方法与定量酶免疫测定法在石蜡包埋乳腺癌组织中雌激素受体的表达情况

Saccani Jotti, G; Johnston, S R; Salter, J; Detre, S; Dowsett, M

Peripheral neuropathy associated with lithium toxicity

锂中毒相关的周围神经病变

Johnston, S R; Burn, D; Brooks, D J